0001161697-23-000629.txt : 20231219 0001161697-23-000629.hdr.sgml : 20231219 20231219170018 ACCESSION NUMBER: 0001161697-23-000629 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231215 FILED AS OF DATE: 20231219 DATE AS OF CHANGE: 20231219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Harper Molly CENTRAL INDEX KEY: 0001871470 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 231498234 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form_4.xml FORM 4 FOR 12-15-2023 X0508 4 2023-12-15 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001871470 Harper Molly 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 1 0 0 0 0 Common stock, par value $0.001 per share 2023-12-15 4 S 0 4000 14.43 D 0 D Common stock, par value $0.001 per share 2023-12-15 4 M 0 10000 5.78 A 10000 D Common stock, par value $0.001 per share 2023-12-15 4 S 0 10000 14.37 D 0 D Options to purchase common stock 5.78 2023-12-15 4 M 0 10000 0 D 2028-06-29 Common Stock 10000 130764 D Shares were sold on the open market for personal reasons and to fund the exercise price of the stock options, and not as a result of any disagreement with the Company. Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $14.37 to $14.40 per share. Options vest in three annual tranches beginning on June 29, 2022. /s/ Molly Harper 2023-12-19